1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 10295 (10th July 2021) Authors: Borobia, Alberto M; Carcas, Antonio J; Pérez-Olmeda, Mayte; Castaño, Luis; Bertran, María Jesús; García-Pérez, Javier; Campins, Magdalena; Portolés, Antonio; González-Pérez, María; García Morales, María Teresa; Arana-Arri, Eunate; Aldea, Marta; Díez-Fuertes, Francisco; Fuentes, Inmaculada; Ascaso... Journal: Lancet Issue: Volume 398:Issue 10295(2021) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 10295 (10th July 2021) Authors: Borobia, Alberto M; Carcas, Antonio J; Pérez-Olmeda, Mayte; Castaño, Luis; Bertran, María Jesús; García-Pérez, Javier; Campins, Magdalena; Portolés, Antonio; González-Pérez, María; García Morales, María Teresa; Arana-Arri, Eunate; Aldea, Marta; Díez-Fuertes, Francisco; Fuentes, Inmaculada; Ascaso... Journal: Lancet Issue: Volume 398:Issue 10295(2021) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗